Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

Date
2009
Author
Yang, Joanna
Kaymakoglu, Sabahattin
Tamez, Ricardo
Tenney, Daniel
Brett-Smith, Helena
Shouval, Daniel
Lai, Ching-Lung
Chang, Ting-Tsung
Cheinquer, Hugo
Martin, Paul
Carosi, Glamplero
Han, Steven
Metadata
Show full item record
Abstract
Background/Aims: To evaluate the off-treatment durability of response in HBeAg-negative chronic hepatitis B patients who achieved a protocol-defined 'Response' (HBV-DNA < 0.7 MEq/mL and ALT < 1.25 x ULN) with entecavir at 48 weeks and the efficacy of entecavir in patients treated beyond one year.
URI
http://hdl.handle.net/20.500.12627/54343
https://doi.org/10.1016/j.jhep.2008.10.017
Collections